Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2488)
All Articles published online
|
Sep 28, 2007 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Billerbeck E, Böttler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007; 13(36): 4858-4864 [PMID: 17828817 DOI: 10.3748/wjg.v13.i36.4858] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i36/4858.htm |
| Number | Citing Articles |
| 1 |
Ji Yoon Bae, Hyung Kyung Kim, Hanna Kang, Ha Rin Cheong, Dong Eun Song, Sun Hee Sung, Heasoo Koo, Woon Sup Han, Jeong Kyong Lee, Tae-Hun Kim, Kyu Won Chung, Min-Sun Cho. Frequency of Intrahepatic FoxP3+ Regulatory T cells during the Natural Course of Chronic Hepatitis B: An Immunohistochemical Study Using Needle-Biopsied Liver Tissue. The Korean Journal of Pathology 2010; 44(2): 132 doi: 10.4132/KoreanJPathol.2010.44.2.132
|
| 2 |
Damião C. M. dos Santos, Patricia C. C. Neves, Elzinandes L. Azeredo, Marcelo Pelajo‐Machado, José Manoel S. G. Martinho, Lúcio F. Pacheco‐Moreira, Cristina C. V. Araújo, Oswaldo Gonçalves Cruz, Jaqueline Mendes de Oliveira, Marcelo Alves Pinto. Activated lymphocytes and high liver expression of IFN‐γ are associated with fulminant hepatic failure in patients. Liver International 2012; 32(1): 147 doi: 10.1111/j.1478-3231.2011.02654.x
|
| 3 |
Wei Li, Jun Han, Hong Wu. Regulatory T‐cells promote hepatitis B virus infection and hepatocellular carcinoma progression. Chronic Diseases and Translational Medicine 2016; 2(2): 67 doi: 10.1016/j.cdtm.2016.09.001
|
| 4 |
Yasuteru Kondo, Masashi Ninomiya, Eiji Kakazu, Osamu Kimura, Tooru Shimosegawa. Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/935295
|
| 5 |
|
| 6 |
ZEHUI YAN, JIJUN ZHOU, MENGJUN ZHANG, XIAOLAN FU, YUZHANG WU, YUMING WANG. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA. Molecular Medicine Reports 2014; 9(5): 2024 doi: 10.3892/mmr.2014.2042
|
| 7 |
Albert S. Reece. HEPATITIS C AND ADDICTION: Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction. Addiction Biology 2009; 14(2): 214 doi: 10.1111/j.1369-1600.2008.00123.x
|
| 8 |
A. Boasso, G. M. Shearer, C. Chougnet. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?. Journal of Internal Medicine 2009; 265(1): 78 doi: 10.1111/j.1365-2796.2008.02043.x
|
| 9 |
Nengqi Lin, Wei Yin, Heather Miller, Maria G. Byazrova, Andrés A. Herrada, Kamel Benlagha, Pamela Lee, Fei Guan, Jiahui Lei, Quan Gong, Youqing Yan, Alexander Filatov, Chaohong Liu. The role of regulatory T cells and follicular T helper cells in HBV infection. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1169601
|
| 10 |
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacologica Sinica 2010; 31(11): 1409 doi: 10.1038/aps.2010.142
|
| 11 |
Shaoyong Li, Lianne E.M. Vriend, Imad A. Nasser, Yury Popov, Nezam H. Afdhal, Margaret J. Koziel, Detlef Schuppan, Mark A. Exley, Nadia Alatrakchi. Hepatitis c virus-specific t-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 2012; 56(6): 2094 doi: 10.1002/hep.25951
|
| 12 |
|
| 13 |
|
| 14 |
Linlin Wang, Xiaocen Wang, Lin Tong, Jian Wang, Maosen Dou, Shimeng Ji, Jing Bi, Cuicui Chen, Dong Yang, Hong He, Chunxue Bai, Jian Zhou, Yuanlin Song. Recovery from acute lung injury can be regulated via modulation of regulatory T cells and Th17 cells. Scandinavian Journal of Immunology 2018; 88(5) doi: 10.1111/sji.12715
|
| 15 |
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Molecular Diagnosis & Therapy 2009; 13(3): 153 doi: 10.1007/BF03256323
|
| 16 |
Xiaojing Wang, Weiming Yan, Yulei Lu, Tao Chen, Ying Sun, Xiaomin Qin, Jiangguo Zhang, Meifang Han, Wei Guo, Hongwu Wang, Di Wu, Dong Xi, Xiaoping Luo, Qin Ning. CD4–CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation. Cellular Immunology 2012; 280(1): 76 doi: 10.1016/j.cellimm.2012.11.010
|
| 17 |
Yanfang Jiang, Wanyu Li, Lei Yu, Jingjing Liu, Guijie Xin, Hongqing Yan, Pinghui Sun, Hong Zhang, Damo Xu, Junqi Niu. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cellular & Molecular Immunology 2011; 8(1): 75 doi: 10.1038/cmi.2010.37
|
| 18 |
Hoda Mohamed El-Emshaty, Wesam Ahmad Nasif, Ibrahim Eldsoky Mohamed. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/707254
|
| 19 |
Robert Thimme, Maura Dandri. Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?. Journal of Hepatology 2013; 58(2): 205 doi: 10.1016/j.jhep.2012.11.007
|
| 20 |
Cecilia G. Giadans, Daniela A. Ríos, Beatriz Ameigeiras, Adriana M. Pietrantonio, Néstor L. Lucatelli, Leila Haddad, Eduardo Mullen, Fabiana Heinrich, Elena De Matteo, Diego Flichman, Pamela Valva, María V. Preciado. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage. Journal of Viral Hepatitis 2019; 26(6): 727 doi: 10.1111/jvh.13078
|
| 21 |
Leonn Mendes Soares Pereira, Samara Tatielle Monteiro Gomes, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00605
|
| 22 |
Rosanna Villani, Gianluigi Vendemiale, Gaetano Serviddio. Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy. International Journal of Molecular Sciences 2018; 20(1): 49 doi: 10.3390/ijms20010049
|
| 23 |
E. Loffredo‐Verde, I. Abdel‐Aziz, J. Albrecht, N. El‐Guindy, M. Yacob, A. Solieman, U. Protzer, D. H. Busch, L. E. Layland, C. U. Prazeres da Costa. Schistosome infection aggravates HCV‐related liver disease and induces changes in the regulatory T‐cell phenotype. Parasite Immunology 2015; 37(2): 97 doi: 10.1111/pim.12171
|
| 24 |
Nora A. Fierro, Flor P. Castro-Garcia, Arturo Panduro. Rethinking cytokine function during hepatitis A and hepatitis C infections. Advances in Bioscience and Biotechnology 2013; 4(07): 13 doi: 10.4236/abb.2013.47A1003
|
| 25 |
Thomas F Baumert, Eloi R Verrier, Michael Nassal, Raymond T Chung, Mirjam B Zeisel. Host-targeting agents for treatment of hepatitis B virus infection. Current Opinion in Virology 2015; 14: 41 doi: 10.1016/j.coviro.2015.07.009
|
| 26 |
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
|
| 27 |
Luca G Guidotti, Masanori Isogawa, Francis V Chisari. Host–virus interactions in hepatitis B virus infection. Current Opinion in Immunology 2015; 36: 61 doi: 10.1016/j.coi.2015.06.016
|
| 28 |
Ahmad Karkhah, Mostafa Javanian, Soheil Ebrahimpour. The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections. Infection, Genetics and Evolution 2018; 59: 32 doi: 10.1016/j.meegid.2018.01.015
|
| 29 |
Leonhard Stross, Johannes Günther, Georg Gasteiger, Theresa Asen, Stefanie Graf, Michaela Aichler, Irene Esposito, Dirk H. Busch, Percy Knolle, Tim Sparwasser, Ulrike Protzer. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 2012; 56(3): 873 doi: 10.1002/hep.25765
|
| 30 |
Julia Schmidt, Hubert E Blum, Robert Thimme. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerging Microbes & Infections 2013; 2(1): 1 doi: 10.1038/emi.2013.14
|
| 31 |
Marc Ringelhan, Tracy O'Connor, Ulrike Protzer, Mathias Heikenwalder. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. The Journal of Pathology 2015; 235(2): 355 doi: 10.1002/path.4434
|
| 32 |
Seyed Hossein Aalaei-Andabili, Seyed Moayed Alavian. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: A systematic review and meta-analysis. Vaccine 2012; 30(38): 5595 doi: 10.1016/j.vaccine.2012.06.063
|
| 33 |
Linlin Wang, Weipeng Jiang, Xiaocen Wang, Lin Tong, Yuanlin Song. Regulatory T cells in inflammation and resolution of acute lung injury. The Clinical Respiratory Journal 2022; 16(9): 587 doi: 10.1111/crj.13527
|
| 34 |
Polyxeni P. Doumba, Elisavet Serti, Maria Boutsikou, Manousos M. Konstadoulakis, Urania Georgopoulou, John Koskinas. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake. Cellular and Molecular Life Sciences 2013; 70(18): 3463 doi: 10.1007/s00018-013-1344-y
|
| 35 |
Vitaly Ablamunits, Octavian Henegariu, Paula Preston‐Hurlburt, Kevan C. Herold. NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti‐CD3 antibody. European Journal of Immunology 2011; 41(7): 1832 doi: 10.1002/eji.201041258
|
| 36 |
|
| 37 |
Margarita Dominguez-Villar, Cecilia Fernandez-Ponce, Alba Munoz-Suano, Esperanza Gomez, Manuel Rodríguez-Iglesias, Francisco Garcia-Cozar. Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein. Clinical Science 2012; 123(1): 15 doi: 10.1042/CS20110631
|
| 38 |
Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Valeria Barili, Eric M. Yoshida, Huy Trinh, Timothy C. Rodell, Diletta Laccabue, Arianna Alfieri, Federica Brillo, Paola Fisicaro, Greta Acerbi, Giuseppe Pedrazzi, Pietro Andreone, Carmela Cursaro, Marzia Margotti, Rosanna Santoro, Valeria Piazzolla, Maurizia R. Brunetto, Barbara Coco, Daniela Cavallone, Yang Zhao, Adarsh Joshi, Jacky Woo, Audrey H. Lau, Anuj Gaggar, G. Mani Subramanian, Benedetta Massetto, Scott Fung, Sang Hoon Ahn, Xiaoli Ma, Alessandra Mangia, Carlo Ferrari. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis. Gastroenterology 2019; 157(1): 227 doi: 10.1053/j.gastro.2019.03.044
|
| 39 |
Leonn M. S. Pereira, Ednelza da Silva Graça Amoras, Simone R. S. da Silva Conde, Sâmia Demachki, Jaqueline C. Monteiro, Rosimar N. Martins-Feitosa, Andrea N. M. R. da Silva, Ricardo Ishak, Antonio C. R. Vallinoto. The −3279C>A and −924A>G polymorphisms in the FOXP3 Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02014
|
| 40 |
Sumathi Ramachandran, David S. Campo, Zoya E. Dimitrova, Guo-liang Xia, Michael A. Purdy, Yury E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection. Journal of Virology 2011; 85(13): 6369 doi: 10.1128/JVI.02204-10
|
| 41 |
Shishir Shetty, David H Adams, Stefan G Hubscher. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2012; 8(7): 645 doi: 10.1586/eci.12.65
|
| 42 |
Ji Hye Hwang, Hyo Won Jung. Effects of the Pharmacopuncture with MOK on Immune Regulation by Th1/Th2 Cytokines in L-Thyroxine-Induced Hyperthyroid Rats. Korean Journal of Acupuncture 2018; 35(2): 91 doi: 10.14406/acu.2018.010
|
| 43 |
Richard C. Duke, Alex Franzusoff, David Apelian. Chronic Viral Hepatitis. 2009; : 471 doi: 10.1007/978-1-59745-565-7_19
|
| 44 |
Abby Harrison, Philippe Lemey, Matthew Hurles, Chris Moyes, Susanne Horn, Jan Pryor, Joji Malani, Mathias Supuri, Andrew Masta, Burentau Teriboriki, Tebuka Toatu, David Penny, Andrew Rambaut, Beth Shapiro. Genomic Analysis of Hepatitis B Virus Reveals Antigen State and Genotype as Sources of Evolutionary Rate Variation. Viruses 2011; 3(2): 83 doi: 10.3390/v3020083
|
| 45 |
Palma A. Iacovazzi, Raffaele Cozzolongo, Elsa Lanzillotta, Stefania Frisullo, Vito Guerra, Mario Correale. Serum 90K/Mac-2 Binding Protein (Mac-2BP) as a Response Predictor to Peginterferon and Ribavirin Combined Treatment in Hcv Chronic Patients. Immunopharmacology and Immunotoxicology 2008; 30(4): 687 doi: 10.1080/08923970802278177
|
| 46 |
Ming-Hsiang Hong, Yu-Chi Chou, Yi-Chieh Wu, Kuen-Nan Tsai, Cheng-po Hu, King-Song Jeng, Mong-Liang Chen, Chungming Chang, Wang-Shick Ryu. Transforming Growth Factor-β1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4α Expression. PLoS ONE 2012; 7(1): e30360 doi: 10.1371/journal.pone.0030360
|
| 47 |
Jinan He, Rui Miao, Yao Chen, Han Wang, Mei Liu. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. Immunology 2024; 171(4): 445 doi: 10.1111/imm.13738
|
| 48 |
Yuming Yu, Joshua Miller, Joseph R. Leventhal, Anat R. Tambur, Dhivya Chandrasekaran, Josh Levitsky, Xunrong Luo, James M. Mathew, Philip J. Norris. Requirement of Cognate CD4+ T-Cell Recognition for the Regulation of Allospecific CTL by Human CD4+CD127−CD25+FOXP3+ Cells Generated in MLR. PLoS ONE 2011; 6(7): e22450 doi: 10.1371/journal.pone.0022450
|
| 49 |
Di Wu, Qin Ning. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome. The Journal of Infectious Diseases 2017; 216(suppl_8): S771 doi: 10.1093/infdis/jix355
|
| 50 |
S.M. Criscione. May viral (antigen) load be the real crucial tool leading to anergy in a “micro-evolutionary” model of host/virus interaction?. Medical Hypotheses 2012; 79(6): 774 doi: 10.1016/j.mehy.2012.08.026
|
| 51 |
Shuo Li, Stefan Floess, Alf Hamann, Silvana Gaudieri, Andrew Lucas, Margaret Hellard, Stuart Roberts, Geza Paukovic, Magdalena Plebanski, Bruce E. Loveland, Campbell Aitken, Simon Barry, Louis Schofield, Eric J. Gowans, Wherry E. John. Analysis of FOXP3+ Regulatory T Cells That Display Apparent Viral Antigen Specificity during Chronic Hepatitis C Virus Infection. PLoS Pathogens 2009; 5(12): e1000707 doi: 10.1371/journal.ppat.1000707
|
| 52 |
Hyosun Cho. The Roles of Immune Regulatory Factors FoxP3, PD-1, and CTLA-4 in Chronic Viral Infection. The Korean Journal of Microbiology 2013; 49(3): 221 doi: 10.7845/kjm.2013.3049
|
| 53 |
Nadia Alatrakchi, Margaret Koziel. Regulatory T cells and viral liver disease. Journal of Viral Hepatitis 2009; 16(4): 223 doi: 10.1111/j.1365-2893.2009.01081.x
|
| 54 |
W. Halota, P. Ferenci, D. Kozielewicz, D. Dybowska, N. Lisovoder, S. Samira, I. Shalit, R. Ellis, Y. Ilan. Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial. Journal of Viral Hepatitis 2015; 22(8): 651 doi: 10.1111/jvh.12369
|
| 55 |
Adam J. Gehring. New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 337 doi: 10.1016/j.bpg.2017.05.004
|